(hyaluronidase (recombinant, human) + trastuzumab)
Marketedupdated 2mo agoby Genentech Inc
Approvedcommunity read0 votes
indications
investigational
Breast Cancer
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that